<DOC>
	<DOCNO>NCT00415090</DOCNO>
	<brief_summary>The purpose study evaluate proportion patient viral load HIV-1 &lt; 50 copy 48 week follow-up randomization change nevirapine .</brief_summary>
	<brief_title>Study Evaluate Replacement Reverse Transcriptase Nucleoside/Nucleotide Inhibitors Nevirapine Patients Triple Treatment With Analogues Only</brief_title>
	<detailed_description>RTNI ( reverse transcriptase nucleoside inhibitor ) regular part antiretroviral combination . The presence small great degree cross resistance among RTNI increasingly well describe acknowledge , whereby number salvage regimen may build follow appearance resistance drug mean unlimited . This proactive treatment change patient RTNI-based regimen viral load still suppress would avoid selective replication period antiviral pressure follow failure regimen resistance-associated mutation accumulate . This therapeutic approach demonstrate effectiveness clinical practice , albeit scenario . If wait viral load detectable sufficient evidence resistance RTNI appear resistance compromise future salvage option . To intensify proactive approach combination base N/NNRTI ( nucleotide analog ) , NNRTI optimal alternative.There vast experience NVP simplification/maintenance trial . In direct comparative simplification study patient virological response , response rate NVP EFV show difference . With relative risk ( RR ) virological failure 0.54 regard continuation PI ( protease inhibitor ) , NVP one best simplification treatment option HIV-1-infected patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Patients triple treatment 3 nucleoside analogue transcriptase nucleotide inhibitor virological suppression . Age &gt; = 18 year . Confirmed diagnosis HIV1 infection . Viral load &lt; 50 copies/ml previous six month , include least two consecutive determination . Value ALT transaminase Â£ 2.5 time normal value laboratory centre . Acceptance signature inform consent form . Pregnant woman intend become pregnant study period . Having active infection previous month . Previous exposure reverse transcriptase nonnucleoside inhibitor ( nevirapine , efavirenz delavirdine ) . Simultaneous treatment methadone . Patients serious hepatic dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Nevirapine</keyword>
	<keyword>Antiretroviral treatment</keyword>
	<keyword>Triple nucleoside therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>